TeamBest Global Calls for Stronger Collaboration with AROI to Advance Affordable Cancer and Vascular Disease Care in India and Worldwide
Dr. Krishnan Suthanthiran, a pioneering entrepreneur and long-standing advocate for equitable and cost-effective healthcare, along with his TeamBest Global family of companies, has issued a comprehensive open letter urging deeper collaboration with the Association of Radiation Oncologists of India (AROI). This call to action emphasizes the urgent need for more accessible, affordable, and technologically advanced solutions in the prevention, diagnosis, and treatment of cancer and vascular diseases both in India and across the globe.
For more than five decades, Dr. Suthanthiran and the TeamBest Global group have been recognized for advancing innovative technologies—particularly in radiation therapy, brachytherapy, and emerging theranostics platforms—that help clinicians deliver high-quality care at significantly reduced costs. Through integrated systems that cover nearly every aspect of clinical workflow, from diagnostics to treatment planning and delivery, TeamBest Global seeks to fundamentally transform global oncology infrastructure.
Central to this mission is the International Society of Therapeutic Radiology and Oncology (ISTRO), which Dr. Suthanthiran founded under the Best Cure Foundation (BCF) and the Brachytherapy Research & Educational Foundation (BREF). Together, these organizations aim to expand global access to high-quality healthcare through the development of Best Cure Pro Health Centers and Best Cure Cancer/Medical Centers. These centers, designed to operate as nonprofit institutions worldwide, will provide comprehensive 24/7 care while manufacturing or sourcing all essential technologies and products required for effective and affordable diagnosis and treatment. By integrating research, education, and clinical services, ISTRO seeks to strengthen global medical ecosystems and accelerate innovation that directly benefits patients.
Investing in Education, Training, and Global Knowledge Exchange
ISTRO’s dedication to advancing the field extends beyond clinical innovation. As part of its ongoing commitment to education and global collaboration, ISTRO and BREF have committed financial support to major international oncology meetings. These include a contribution of 100,000 INR and USD $5,000 to the AROI 2026 conference in Kolkata, India, as well as support for the ACRO Brachytherapy Conference in Medellín, Colombia.
These contributions will fund ISTRO Awards, which will be granted directly by conference organizers to distinguished researchers, clinicians, or trainees. The aim is to recognize excellence, encourage emerging leaders, and promote new ideas that can accelerate progress in radiation oncology, brachytherapy, and cost-effective diagnosis and treatment technologies.
Such investments underline TeamBest Global’s long-standing belief that education and collaboration are essential for driving meaningful improvements in patient outcomes. By encouraging knowledge-sharing across borders, the organization hopes to empower the next generation of clinicians while ensuring that innovations reach underserved populations.
A Vision for Global Health Transformation
In his letter, Dr. Suthanthiran highlights the critical need to shift global healthcare systems toward a more preventive and cost-effective model. He underscores that proactive primary care—comprising routine medical, dental, and eye evaluations—combined with access to advanced diagnostic and treatment technologies, could reduce global mortality from all diseases by nearly 50%. This conclusion aligns with findings previously published in The Lancet, reinforcing that early detection and timely treatment remain the most powerful tools in reducing mortality.
TeamBest Global’s proposed Best Cure Pro Health Centers embody this philosophy. These centers are designed to provide a full spectrum of services—including wellness programs, advanced imaging, precision diagnostics, radiation therapy, and vascular disease management—within community-based settings that are accessible and affordable.
The organization’s nonprofit model also means that revenue will be reinvested into expanding services, improving technologies, and further subsidizing care for those who cannot afford it. Through this framework, Dr. Suthanthiran and his team hope to build a sustainable healthcare ecosystem that prioritizes prevention, quality, and affordability over profit.
A Call for Partnership with AROI
Dr. Suthanthiran’s open letter respectfully calls on the Board of Directors of AROI to deepen its engagement with ISTRO, BCF, BREF, TeamBest Global, and the broader network of experts involved in the Best Cure mission. By strengthening these partnerships, the organizations aim to:
- Expand India’s leadership role in cancer treatment and research
- Enhance quality and affordability of care
- Encourage adoption of innovative, cost-effective technologies
- Train clinicians in the most advanced diagnostic and therapeutic methods
- Develop long-term strategies to address India’s growing cancer burden
The letter emphasizes that India is uniquely positioned to shape the future of global healthcare. With a population of 1.5 billion, a rapidly expanding healthcare infrastructure, and a deep pool of highly skilled clinicians, researchers, and medical technologists, India plays a central role in worldwide medical progress. Indian-trained physicians serve across continents, and in the United States, Indo-Americans now represent the second-largest group of medical practitioners after American-born doctors.
India’s Global Leadership: Encouraged at the Highest Levels
During the September 2024 Quad meeting held in Washington, D.C., former U.S. President Joseph Biden encouraged Indian Prime Minister Narendra Modi to position India at the forefront of global healthcare—particularly in combating cancer, one of the world’s fastest-growing and most challenging health crises. Recognizing India’s growing influence in the medical field, leaders at the meeting emphasized the importance of expanding research partnerships, accelerating clinical innovation, and increasing access to high-quality treatment technologies.
Responding to this vision, BCF, BREF, and TeamBest Global reaffirm their commitment to launching the first of many Best Cure Pro Health and Best Cure Medical Centers across India. The inaugural centers are scheduled to open in 2026 in Coimbatore and Tirupur, Tamil Nadu. These flagship facilities will focus on advanced diagnosis and treatment of:
- Cancer
- Cardiovascular and vascular diseases
- Diabetes and metabolic disorders
- Infectious diseases
- Other major chronic and acute health conditions
These centers will serve as models for replication across additional Indian states and major global regions, forming the backbone of a future worldwide network dedicated to equitable, high-quality care.
Building a Future Where High-Quality Care Is Truly Universal
The open letter closes with a strong message: meaningful progress in cancer and vascular disease care requires collective action. No single organization or institution can solve these challenges alone. By building closer partnerships, leveraging each other’s strengths, and promoting transparent collaboration, the community can drive transformative improvements that benefit millions.
Dr. Suthanthiran’s call is ultimately an invitation—one extended not only to AROI but to policymakers, clinicians, educators, and innovators throughout India and worldwide. The shared goal is clear: ensure that every person, regardless of geography or income, has access to the best possible care.
TeamBest Global remains committed to advancing this mission through nonprofit healthcare delivery, state-of-the-art technology development, and unwavering dedication to education and global health equity.
